influenza
nucleoprotein
np
attract
target
avian
flu
vaccin
develop
high
convers
evolutionari
chain
viru
identifi
two
novel
hlaa
restrict
np
epitop
name
amdsntlel
fqgrgvfel
use
comput
bioinformat
analysi
np
peptid
show
high
bind
affin
hlaa
cell
abl
induc
activ
cytotox
cell
human
peripher
blood
mononuclear
cell
examin
potenti
use
peptid
sequenc
supplement
singlechain
trimer
potenti
dna
vaccin
candid
hhd
transgen
mous
model
gene
gun
deliveri
system
use
administr
vaccin
candid
anim
result
cytotox
elispot
assay
indic
signific
amount
ifnc
secret
cell
vaccin
mice
cell
abl
elimin
correspond
peptideload
cell
discoveri
novel
immunogen
np
peptid
provid
valuabl
inform
avian
flu
vaccin
design
construct
influenza
viru
nucleoprotein
hlaa
tcell
epitop
singlechain
trimer
hhd
transgen
mous
model
correspond
author
boyxi
usthk
transmiss
pathogen
avian
viru
poultri
human
hong
kong
asian
countri
caus
number
human
death
confirm
case
transmiss
also
report
variou
african
european
countri
incid
caus
enorm
econom
loss
poultri
industri
worldwid
threat
pandem
becom
major
problem
asian
countri
countri
worldwid
urgenc
develop
strategi
combat
viru
imper
task
health
author
one
possibl
solut
develop
human
vaccin
viru
product
neutral
antibodi
primari
step
combat
viral
infect
anoth
import
mechan
viru
elimin
initi
cellmedi
immun
respons
involv
induct
effector
cytotox
lymphocyt
ctl
conserv
compon
within
influenza
viral
genom
good
target
induc
ctl
respons
withstand
viral
mutat
capabl
induc
crossreact
immun
respons
among
differ
subtyp
variat
nucleoprotein
np
gener
bind
viral
rna
synthes
larg
amount
viral
replic
within
infect
cell
influenza
viru
np
compar
conserv
protein
record
evolut
viral
strain
bird
past
year
therefor
high
conserv
evolut
viru
np
attract
target
induc
tcell
immun
one
promis
approach
involv
direct
dna
vaccin
stimul
tcell
immun
np
dna
vaccin
recombin
viral
vaccin
constitut
adenoviru
encod
whole
np
gene
found
effect
elicit
tcell
immun
previous
show
singlechain
trimer
sct
system
promis
system
use
construct
dna
vaccin
identifi
two
novel
hlaa
peptid
modifi
sct
system
use
vaccin
construct
efficaci
construct
vaccin
candid
investig
special
genet
modifi
hhd
transgen
mous
model
result
suggest
amdsntlel
fqgrgvfel
peptid
might
promis
candid
use
vaccin
construct
np
peptid
strain
predict
hlapeptidebind
predict
program
syfpeithi
nine
potenti
peptid
synthes
solidphas
strategi
name
klsdyegrl
rliqnsiti
gmdprmcsl
mvmelirmi
liflars
clpacvygl
qlstrgvqi
amdsntlel
fqgrgvfel
peptid
previous
identifi
lalllldrl
use
posit
control
hhd
transgen
doubl
knockout
mice
week
old
purchas
institut
pasteur
franc
bred
maintain
pathogenfre
condit
anim
plant
care
facil
hkust
hong
kong
china
hhd
mice
origin
deriv
mice
mous
b
microglobulin
mhc
knockout
hlaa
knockin
express
chimer
hla
classi
molecul
compos
human
b
microglobulin
hlaa
domain
domain
b
recombin
np
express
plu
ril
cell
stratagen
la
jolla
ca
usa
solubl
np
purifi
hisbind
kit
novagen
san
diego
ca
usa
purifi
protein
analyz
confirm
sdspage
western
blot
analysi
perform
use
antiinfluenza
np
antibodi
chemicon
billerica
usa
cell
atcc
manassa
va
usa
identifi
hlaa
posit
transport
antigenprocessingdefici
cell
cell
maintain
imdm
medium
invitrogen
carlsbad
ca
usa
supplement
fb
invitrogen
uml
penicillin
lgml
streptomycin
invitrogen
carbon
dioxid
bind
assay
cell
puls
target
np
peptid
lgml
respect
serumfre
medium
contain
human
b
microglobulin
lgml
h
cell
wash
pb
stain
fitcconjug
antihuman
antibodi
bd
pharmingen
san
diego
ca
usa
final
subject
flow
cytometr
analysi
bd
fasc
aria
ii
bd
bioscienc
san
jose
ca
usa
fluoresc
index
calcul
formula
follow
fi
mfi
peptid
mfi
flu
peptid
gilgfvftl
use
posit
control
intracellular
cytokin
stain
perform
previous
describ
minor
modif
briefli
prime
cell
incub
peptideload
cell
presenc
brefeldin
ebiosci
san
diego
ca
usa
h
cell
stain
peconjug
antihuman
antibodi
ebiosci
min
wash
pb
cell
fix
permeabil
permeabil
buffer
ebiosci
accord
manufactur
instruct
cell
final
stain
fitcconjug
antihuman
ifnc
antibodi
min
dark
fluoresc
signal
detect
flow
cytometr
analysi
bd
fasc
aria
ii
bd
bioscienc
cell
load
previous
identifi
nonrespons
peptid
lqlpqgttl
use
neg
experiment
control
plasmid
includ
prepar
follow
brief
singlechain
trimer
gene
hhd
construct
connect
leader
sequenc
human
b
microglobulin
human
hlaa
domain
mous
b
domain
subsequ
clone
vector
invitrogen
plasmid
encod
differ
peptid
sequenc
construct
ad
correspond
dna
fragment
leader
sequenc
hhd
use
pcr
follow
primer
sens
atcgaccggtctatatgctgg
aatggaccctcggatgtgttccctgggagga
atcgaccggtctata
tgctatggtgatggagctgatcagaatgatcg
atcgaccgg
tctatatgctgccatggacagcaacaccctgg
atc
gaccggtctatatgctttccagggacgggga
antisens
atcgctcgagtcacgctttacaat
primer
construct
fragment
clone
age
xho
site
express
identifi
hlaa
epitop
use
control
plasmid
anim
vaccin
carri
gene
gun
deliveri
system
prepar
dnacoat
gold
particl
cartridg
perform
previous
describ
briefli
cartridg
prepar
precipit
plasmid
dna
lm
gold
particl
biorad
hercul
ca
usa
spermidin
sigmaaldrich
corp
cacl
microcarrierdna
suspens
mix
polyvinylpyrrolidon
mgml
sigmaaldrich
corp
coat
plastic
tube
coat
tube
cut
inch
cartridg
cartridg
contain
lg
dna
dnacoat
particl
deliv
shave
abdomin
region
hhd
mice
use
helio
gene
gun
biorad
hercul
ca
usa
discharg
pressur
psi
mice
receiv
dna
lg
vaccin
anim
group
three
mice
per
group
receiv
total
three
vaccin
interv
cytotox
assay
perform
use
delfia
eutda
cytotox
detect
kit
perkinelm
waltham
usa
mice
sacrif
week
last
vaccin
splenocyt
extract
splenocyt
cultur
imdm
medium
invitrogen
supplement
fb
invitrogen
correspond
target
peptid
lgml
uml
ebiosci
plate
bd
bioscienc
day
seed
tdalabel
peptideload
cell
tcell
epitop
nucleoprotein
vet
re
ratio
respect
mice
immun
use
experi
control
splenocyt
seed
cell
use
posit
control
seed
cell
serv
neg
control
incub
h
cultur
medium
collect
fluoresc
signal
emit
dead
peptideload
cell
detect
cytotox
reagent
accord
procedur
state
manufactur
cytotox
determin
follow
equat
two
control
set
cytotox
assay
maximum
releas
measur
peptideload
cell
lyze
lysi
buffer
spontan
releas
measur
natur
releas
peptideload
cell
elispot
assay
perform
previous
describ
minor
modif
briefli
nitrocellulos
plate
multiscreenha
millipor
billerica
usa
coat
antimous
ifnc
antibodi
lgml
ebiosci
h
follow
block
imdm
medium
invitrogen
supplement
fb
invitrogen
h
splenocyt
seed
four
well
nitrocellulos
plate
correspond
target
peptid
lgml
ad
plate
incub
h
mice
immun
use
experi
control
splenocyt
peptid
ad
use
posit
control
ad
peptid
serv
neg
control
subsequ
plate
wash
pb
contain
tween
incub
biotinyl
antimous
ifnc
antibodi
lgml
ebiosci
room
temperatur
h
wash
streptavidinap
solut
lgml
sigmaaldrich
corp
ad
plate
incub
room
temperatur
min
final
wash
spot
develop
ad
bcipnbt
solut
invitrogen
visibl
spot
count
elispot
reader
thermo
labsystem
franklin
usa
two
control
group
splenocyt
set
elispot
assay
splenocyt
without
addit
peptid
use
neg
control
splenocyt
staphylococc
enterotoxin
b
sigmaaldrich
corp
ad
use
posit
control
statist
analysi
express
mean
standard
error
se
comparison
individu
read
perform
use
student
ttest
p
valu
regard
statist
signific
order
search
immunogen
np
peptid
sequenc
nine
potenti
peptid
predict
use
syfpeithi
softwar
variou
assay
use
determin
immunogen
peptid
desir
one
ie
highest
bind
affin
hlaa
posit
cell
abil
stimul
human
cell
select
vivo
experiment
order
determin
bind
affin
hlaa
posit
cell
peptid
synthes
bind
assay
perform
cell
normal
express
unstabl
hla
molecul
cell
surfac
therefor
peptid
abl
fit
peptidebind
groov
hla
molecul
form
stabl
structur
complex
hla
molecul
presenc
b
microglobulin
complex
detect
antihuman
antibodi
via
flow
cytometri
assay
flu
peptid
gilgfvftl
hlaa
epitop
use
posit
control
experi
result
indic
amdsntlel
mvmelirmi
fqgrgvfel
show
highest
score
bind
assay
fig
potenti
nine
peptid
stimul
human
cell
also
determin
two
group
cell
isol
pbmc
two
healthi
donor
respect
prime
autolog
matur
npload
dc
three
time
intracellular
cytokin
stain
perform
detect
releas
ifnc
cell
peptideload
cell
use
target
cell
np
process
dc
combin
hla
molecul
eventu
becom
present
cell
surfac
prime
cell
prime
cell
could
therefor
recogn
peptidemhc
complex
cell
target
peptid
process
present
dc
surfac
result
intracellular
cytokin
stain
show
highest
number
ifncsecret
cell
produc
stimul
mvmelirmi
amdsntlel
fqgrgvfel
peptid
lowest
number
stimul
cell
observ
stimul
gmdprmcsl
peptid
lqlpqgttl
peptideload
cell
use
neg
control
show
signific
chang
fig
result
two
assay
select
four
target
peptid
gmdprmcsl
mvmelirmi
amdsntlel
fqgrgvfel
anim
experiment
base
find
three
peptid
show
highest
bind
affin
molecul
abl
activ
highest
number
cell
sinc
gmdprmcsl
exhibit
compar
low
abil
stimul
cell
peptideload
cell
induc
small
amount
ifnc
releas
includ
sampl
peptid
control
check
consist
result
previous
shown
vitro
tcell
stimul
experi
anim
experi
perform
test
immunogen
target
peptid
vivo
dna
correspond
target
peptid
clone
hhd
gene
produc
dna
vaccin
candid
contain
peptideb
microglobulinmhc
classi
heavi
chain
complex
could
express
cell
surfac
trigger
immun
system
mice
receiv
total
three
administr
sacrif
week
last
inject
splenocyt
collect
cytotox
elispot
assay
cytotox
measur
amount
tda
releas
target
cell
target
cell
cell
load
target
peptid
therefor
peptideload
cell
would
kill
correspond
peptid
immunogen
mice
result
cytotox
assay
show
highest
percentag
cytotox
respons
trigger
mice
immun
plasmid
encod
effect
similar
produc
posit
control
h
incub
period
exhibit
kill
effici
effector
celltotarget
cell
ratio
respect
exhibit
kill
effici
effector
celltotarget
cell
ratio
respect
howev
kill
effici
cell
trigger
compar
low
effector
celltotarget
cell
ratio
result
produc
significantli
lower
kill
effici
effector
celltotarget
cell
ratio
fig
elispotassay
use
determin
splenocyt
recognit
correspond
peptid
via
ifnc
releas
anim
immun
largest
number
splenocyt
appear
spot
produc
mice
immun
contain
sctdna
construct
spot
respect
contrast
spot
observ
anim
immun
contain
sctdna
construct
respect
result
similar
neg
control
spot
immunogen
trigger
mice
compar
low
compar
result
bind
assay
intracellular
cytokin
stain
nonetheless
result
indic
immunogen
time
higher
induc
fig
predict
process
repeat
predict
score
indic
may
abl
bind
varieti
hla
type
tab
hlaa
global
common
hla
type
occur
high
frequenc
popul
northern
southeast
asia
north
america
studi
select
nine
peptid
might
potenti
vaccin
candid
human
influenza
use
hlapeptidebind
predict
program
two
novel
epitop
specif
np
found
name
amdsntlel
fqgrgvfel
repeat
predict
process
investig
bind
two
identifi
epitop
hla
type
tab
found
two
epitop
might
abl
bind
hla
type
therefor
experiment
may
requir
confirm
predict
ideal
vaccin
capabl
counteract
infecti
virus
abl
trigger
neutral
antibodi
product
cytotox
tcell
respons
critic
process
elimin
viru
viral
pathogenesi
previous
mention
current
studi
vaccin
mainli
focus
gener
neutral
antibodi
anoth
research
stream
involv
studi
cellmedi
immun
epitop
found
differ
intern
protein
influenza
viru
differ
hla
type
amongst
identifi
epitop
np
epitop
categor
hlab
type
decid
examin
np
epitop
bind
specif
hlaa
cell
desir
peptid
sequenc
induc
cytotox
tcell
respons
present
endogen
peptid
epitop
proteasom
digest
high
bind
affin
toward
human
mhc
classi
molecul
therefor
apart
bind
assay
stimul
abil
predict
peptid
also
access
via
vitro
stimul
use
human
pbmc
vitro
stimul
carri
prime
cell
natur
process
np
peptid
autolog
dc
result
show
peptid
stimul
strongest
immun
respons
amongst
four
peptid
use
bind
affin
bind
assay
rel
high
signific
chang
immun
respons
observ
vitro
administr
human
pbmc
result
produc
similar
neg
control
suggest
peptid
predict
softwar
give
comput
estim
immunogen
potenti
vaccin
candid
henc
predict
epitop
may
truli
reflect
experiment
condit
vitro
mimic
real
state
vivo
natur
process
peptid
present
hla
molecul
significantli
contribut
magnitud
immun
respons
experi
number
cell
detect
via
intracellular
cytokin
stain
high
expect
compar
whole
pool
cell
normal
natur
process
epitop
npload
dc
present
cell
base
crosspresent
characterist
dc
therefor
activ
cell
respons
immunogen
epitop
present
np
experi
target
cell
load
singl
type
target
peptid
may
explain
low
percentag
cell
activ
caus
correspond
peptidespecif
cell
observ
use
sct
approach
construct
peptid
vaccin
candid
method
peptid
abl
specif
bind
peptidebind
cleft
creat
hlaa
domain
phenomenon
imit
natur
bind
peptid
onto
mhc
classi
molecul
normal
antigen
process
also
sct
system
ensur
stabil
mhc
ipeptid
complex
translat
precis
direct
prime
profession
antigen
present
cell
cytotox
cell
achiev
henc
stimul
effici
peptid
vaccin
greatli
maxim
select
peptid
test
cytotox
cell
stimul
abil
vivo
use
hhd
transgen
mous
model
hhd
special
mous
type
lack
mous
b
microglobulin
mhc
contain
human
b
microglobulin
hlaa
well
mous
fusion
gene
genet
modifi
mous
immun
system
imperson
human
system
immun
respons
stimul
restrict
reaction
hlaa
tcell
receptor
elimin
background
caus
mous
mhc
classi
molecul
experi
cytotox
elispot
assay
show
amdsntlel
fqgrgvfel
immunogen
peptid
reactiv
two
peptid
consist
test
process
epitop
identif
anoth
target
peptid
although
show
good
respons
bind
assay
vitro
stimul
human
cell
induc
weak
respons
anim
experi
anoth
indic
vitro
system
reflect
vivo
situat
nonetheless
vitro
experi
essenti
acquir
basic
inform
verifi
characterist
potenti
peptid
discov
immunogen
peptid
sinc
test
peptid
perform
clinic
trial
without
extens
investig
bind
assay
good
methodolog
examin
potenti
bind
affin
target
peptid
groov
hlaa
molecul
antigen
process
present
magnitud
tcell
respons
correspond
stimul
investig
via
vitro
stimul
cell
believ
hhd
transgen
mous
model
appropri
anim
model
investig
stimul
effect
peptidehla
complex
correspond
tcell
respons
summari
identifi
two
novel
hlaa
tcell
epitop
viral
np
result
indic
two
epitop
capabl
induc
strong
immun
respons
sct
system
improv
immun
respons
find
novel
cytotox
tcell
epitop
present
provid
signific
inform
develop
human
vaccin
futur
experi
use
mixtur
sctdna
construct
encod
np
epitop
instead
use
one
type
sctdna
construct
encod
singl
peptid
necessari
investig
whether
improv
immunogen
